Wound Closure Strips Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Flexible, Reinforced), By Product Sterility (Sterile, Non-Sterile), By Indication (Surgical Wounds, Laceration & Minor Cuts), By End use (Hospitals, Specialty Clinics, Home Care, Others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 0.47 Billion
CAGR (2026-2031)	5.82%
Fastest Growing Segment	Flexible
Largest Market	North America
Market Size (2031)	USD 0.66 Billion

Market Overview

The Global Wound Closure Strips Market will grow from USD 0.47 Billion in 2025 to USD 0.66 Billion by 2031 at a 5.82% CAGR. The Global Wound Closure Strips Market encompasses the production and supply of sterile, adhesive tapes designed to approximate wound edges, serving as a non-invasive alternative or supplement to sutures for securing surgical incisions and lacerations. The market’s growth is primarily driven by the rising global volume of surgical procedures, an increasing patient preference for aesthetic healing outcomes with reduced scarring, and the cost-effectiveness of these products in ambulatory settings. According to the American College of Surgeons, in 2024, the organization’s membership exceeded 93,000 surgeons globally, reflecting the expanding workforce of professionals who necessitate reliable and efficient wound closure solutions to manage the increasing procedural caseload.

Despite these positive growth indicators, a significant challenge that could impede market expansion is the risk of adhesive-related skin injuries, such as blistering or allergic contact dermatitis, particularly among patients with fragile or compromised skin. This material limitation often compels healthcare providers to select alternative closure modalities, such as tissue adhesives or staples, for high-tension wounds or sensitive areas. Consequently, the inability to guarantee secure adhesion without skin trauma in all patient demographics remains a barrier to the universal adoption of wound closure strips across complex surgical applications.

Key Market Drivers

The Rising Global Volume of Surgical Procedures stands as a primary catalyst propelling the Wound Closure Strips Market, driven by the expanding prevalence of cosmetic and reconstructive interventions that necessitate superior aesthetic results. As healthcare providers increasingly prioritize minimal scarring and rapid recovery, the adoption of non-invasive closure modalities like sterile adhesive strips has surged, particularly for low-tension incisions where traditional sutures might compromise the cosmetic outcome. This trend is substantiated by the growing caseload in aesthetic medicine, which generates consistent demand for high-quality closure solutions. According to the International Society of Aesthetic Plastic Surgery (ISAPS), June 2025, in the 'Global Survey on Aesthetic/Cosmetic Procedures', board-certified plastic surgeons performed over 17.4 million surgical procedures worldwide in 2024, highlighting the substantial addressable market for aesthetic-focused wound management products.

Simultaneously, the Increasing Incidence of Trauma and Accident Cases is significantly accelerating market momentum, as emergency departments require rapid and effective closure methods for lacerations and minor wounds. In trauma settings, wound closure strips offer a time-efficient alternative to stapling or suturing, reducing patient anxiety and the need for follow-up removal visits, which is crucial for managing high patient throughput. The urgency of this demand is reflected in recent accident statistics that underscore the persistent burden of injury-related care. According to the National Safety Council, October 2025, in the 'Injury Facts' database, provisional estimates indicated that motor vehicle deaths in the United States reached 18,720 in the first six months of 2025 alone, reflecting the critical volume of trauma cases often accompanied by non-fatal injuries requiring closure. This continued pressure on healthcare systems contributes to the sector's financial expansion; according to ConvaTec Group Plc, February 2025, in the 'Annual Report and Accounts 2024', the company’s Advanced Wound Care division reported an organic revenue growth of 7.4%, illustrating the robust commercial trajectory of the wider wound management industry.

Download Free Sample Report

Key Market Challenges

The primary challenge impeding the Global Wound Closure Strips Market is the substantial risk of adhesive-related skin injuries, including blistering and contact dermatitis, which severely restricts product usage in patients with fragile or compromised skin. This material limitation forces healthcare providers to bypass adhesive strips in favor of alternative closure modalities, such as staples or sutures, to avoid exacerbating tissue trauma in vulnerable populations. Consequently, the market struggles to achieve universal adoption in complex clinical settings, as the inability to guarantee secure adhesion without damaging the surrounding skin renders these products unsuitable for a significant segment of surgical patients.

This barrier is critically underscored by the persistent prevalence of skin fragility in aging populations, which represents a key demographic for surgical procedures. According to the Tissue Viability Society, in 2024, the pooled prevalence of skin tears among older adults was 6.0%. This statistic highlights that a meaningful proportion of the patient population possesses skin too delicate for standard adhesive applications. As clinicians prioritize the prevention of medical adhesive-related skin injury (MARSI), the demand for wound closure strips is directly curtailed in these high-risk sectors, thereby limiting the overall market expansion.

Key Market Trends

The Integration of Antimicrobial Agents in Closure Strips is gaining significant traction as healthcare facilities strive to reduce the incidence of preventable hospital-acquired complications. Standard adhesive strips can inadvertently harbor pathogens, prompting manufacturers to embed active ingredients like silver or iodine directly into the material to create a sterile barrier during the critical healing phase. This innovation is becoming indispensable, particularly as infection rates in surgical settings remain a persistent concern despite standard sterilization protocols. According to the Centers for Disease Control and Prevention (CDC), November 2024, in the '2023 National and State Healthcare-Associated Infections Progress Report', there was a 3% increase in surgical site infections (SSIs) associated with combined Surgical Care Improvement Project (SCIP) procedures between 2022 and 2023, highlighting the urgent clinical necessity for closure products that offer prophylactic antimicrobial properties.

Simultaneously, the Expansion into Home Healthcare and DIY Wound Care is reshaping market dynamics, fueled by the push for shortened hospital stays and greater patient autonomy. As recovery increasingly shifts to domestic settings, there is a heightened demand for user-friendly wound management solutions that non-professionals can apply and monitor effectively without frequent clinical visits. This transition is driving robust commercial performance for companies specializing in adaptable wound care technologies suitable for outpatient use. According to Smith+Nephew, February 2025, in the 'Fourth Quarter and Full Year 2024 Results', the company’s Advanced Wound Management business unit delivered an underlying revenue growth of 12.2% in the fourth quarter, reflecting the accelerated adoption of sophisticated wound care modalities across diverse care settings, including the expanding home-use segment.

Segmental Insights

The Flexible segment is currently the fastest-growing category in the Global Wound Closure Strips Market. This rapid expansion is driven by the increasing preference for closure solutions that offer superior conformability to body contours and accommodate patient mobility. Unlike reinforced counterparts, flexible strips stretch with natural skin movement and post-operative swelling, significantly reducing the risk of shear injuries and traction blisters. Furthermore, continuous improvements in breathable elastic materials and hypoallergenic adhesives have enhanced their efficacy for use on joints and high-motion areas. These clinical benefits, combined with improved cosmetic outcomes, are accelerating their adoption across healthcare settings globally.

Regional Insights

North America maintains a dominant position in the Global Wound Closure Strips Market primarily due to a well-established healthcare infrastructure and a high volume of surgical procedures. The region benefits from the strong presence of key industry manufacturers and rising adoption of non-invasive wound care solutions. Furthermore, the stringent safety guidelines and product standards overseen by the U.S. Food and Drug Administration foster a reliable environment for product innovation and clinical usage. Widespread availability of reimbursement coverage for hospital-based care further supports the sustained demand for wound closure products across the United States and Canada.

Recent Developments

• In November 2025, Solventum entered into a definitive agreement to acquire Acera Surgical, a privately held medical device company specializing in soft tissue repair, for an upfront payment of $725 million and potential additional milestones. This acquisition was intended to bolster the company's advanced wound care portfolio by adding a fully resorbable synthetic matrix platform used for complex wound healing. The transaction, valued at up to $850 million, aligned with the company's strategy to expand its presence in the biologics and wound management market. This move complemented its existing range of negative pressure therapies and adhesive closure products, aiming to provide more comprehensive solutions for acute care settings.
• In November 2025, SYNDEO Medical announced that it had secured multiple international regulatory approvals for the Clozex Advanced Wound Closure device. These approvals marked a significant expansion for the non-invasive, needle-free skin closure technology into new global markets. The device, which utilizes a unique interlaced design to approximate skin edges without sutures or staples, was recognized for its ability to reduce procedure time and improve cosmetic results. This regulatory milestone allowed the company to broaden the distribution of its adhesive-based closure system, offering healthcare providers in additional regions an alternative method for treating lacerations and surgical incisions.
• In September 2024, Corza Medical received the "Most Innovative Wound Closure Products Manufacturer – 2024 USA" award from Global Health & Pharma Magazine. This accolade recognized the medical technology company for its commitment to developing high-performance surgical technologies and advancing patient outcomes. The organization was highlighted for its comprehensive portfolio of wound closure solutions, which includes high-quality suture technologies and non-invasive closure devices distributed under partnership agreements. The award selection process evaluated the company’s digital presence, client reviews, and contributions to the healthcare sector, acknowledging its role in supporting clinicians with effective wound management tools.
• In April 2024, Solventum Corporation formally launched as an independent, publicly traded healthcare company following its spin-off from a multinational conglomerate. The newly formed entity, which houses a leading portfolio of wound care solutions including the widely used reinforced adhesive skin closures, began trading on the New York Stock Exchange. This strategic separation was designed to allow the business to tailor its capital allocation and innovation strategies specifically toward medical and surgical markets. As a standalone company, Solventum continues to manufacture and market its established range of non-invasive wound closure products that are standard in operating rooms and clinics globally.

Key Market Players

• 3M
• Johnson & Johnson
• Smith & Nephew
• BSN Medical
• Mölnlycke
• Medline
• Coloplast
• Hollister
• Swann-Morton
• Integra LifeSciences

By Product Type	By Product Sterility	By Indication	By End use	By Region
Flexible Reinforced	Sterile Non-Sterile	Surgical Wounds Laceration & Minor Cuts	Hospitals Specialty Clinics Home Care Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Wound Closure Strips Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Wound Closure Strips Market, By Product Type:

• Flexible
• Reinforced

• Wound Closure Strips Market, By Product Sterility:

• Sterile
• Non-Sterile

• Wound Closure Strips Market, By Indication:

• Surgical Wounds
• Laceration & Minor Cuts

• Wound Closure Strips Market, By End use:

• Hospitals
• Specialty Clinics
• Home Care
• Others

• Wound Closure Strips Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE